For the first time, FDA regulators will be able to see what’s happening in a clinical trial, looking at endpoints in the ...

The charges against Morens come after Congressional probes related to the origins of the virus that causes Covid-19.

The Supreme Court on Wednesday will hear oral arguments about a simmering controversy over so-called skinny labels, with implications for the availability of generics.

Eli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and more biotech news today ...

The Novartis CEO warned that Trump's drug pricing policy poses a “very difficult situation” and the reality will soon catch ...

Policy that recommends offering hep B vaccine at birth only to babies perceived to be at risk will lead to increased numbers ...

In this edition of STAT Health Tech newsletter: a conversation with Google's clinical director, an update on Doctronic's Utah ...

Eli Lilly's deal with Profluent aims to go beyond CRISPR by using AI-designed enzymes to insert entire genes. It could ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...

Failing to adopt a more inclusive concept of brain health represents a massive loss of human potential,” write Husseini K.

The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer ...

This could be the start of serious action on microplastics. Or it could end up as a headline with little behind it,” write ...